Patents Assigned to Weaver Labs, LLC
  • Patent number: 12662397
    Abstract: The present disclosure provides compounds of Formula (I), their methods of preparation, their methods of regeneration of the compound of Formula (I), and their methods of use for binding perfluoroalkyl substances (PFAS) contaminates from sources of PFAS contaminated water.
    Type: Grant
    Filed: May 17, 2023
    Date of Patent: June 23, 2026
    Assignee: Weaver Labs, LLC
    Inventors: Anuradha Singh, Jimmie D. Weaver, Richard Lynch, Jacob Solomon
  • Patent number: 11780817
    Abstract: The present invention provides methods for preparing Favipiravir (6-fluoro-3-hydroxypyrazine-2-carboxamide).
    Type: Grant
    Filed: May 18, 2021
    Date of Patent: October 10, 2023
    Assignee: Weaver Labs, LLC
    Inventors: Jimmie Dean Weaver, III, Anuradha Singh
  • Publication number: 20210355090
    Abstract: The present invention provides methods for preparing Favipiravir (6-fluoro-3-hydroxypyrazine-2-carboxamide).
    Type: Application
    Filed: May 18, 2021
    Publication date: November 18, 2021
    Applicant: Weaver Labs, LLC
    Inventors: Jimmie Dean Weaver, III, Anuradha Singh